Costs of HIV/AIDS treatment in Indonesia by time of treatment and stage of disease

Evaluating Total Lymphocyte Count as a Surrogate Marker for CD4 Cell Count in the Management of HIV-Infected Patients in Resource-Limited Settings: A Study from China

(2013) Jieqing Chen et al.   PLoS One

Total lymphocyte count as a surrogate marker for CD4 count in resource-limited settings

(2012) Christian Obirikorang et al.   BMC INFECTIOUS DISEASES

Total Lymphocyte Count as surrogate marker for CD4 Cell Count in HIV-Infected Individuals in Gondar University Hospital, Northwest Ethiopia

(2012) Yitayih Wondimeneh et al.   AIDS Research and Therapy

Prevention of HIV-1 Infection with Early Antiretroviral Therapy

(2011) Myron S. Cohen et al.   NEW ENGLAND JOURNAL OF MEDICINE

Total lymphocyte count is a good marker for HIV-related mortality and can be used as a tool for starting HIV treatment in a resource-limited setting

(2011) Helena P. W. Oudenhoven et al.   TROPICAL MEDICINE & INTERNATIONAL HEALTH

Treatment Outcomes and Cost-Effectiveness of Shifting Management of Stable ART Patients to Nurses in South Africa: An Observational Cohort

(2011) Lawrence Long et al.   PLOS MEDICINE

Cost‐Effectiveness of Tenofovir as First‐Line Antiretroviral Therapy in India

(2010) Melissa A. Bender et al.   CLINICAL INFECTIOUS DISEASES

The financial burden of HIV care, including antiretroviral therapy, on patients in three sites in Indonesia

(2010) S. Riyarto et al.   HEALTH POLICY AND PLANNING

HIV prevention, treatment, and care services for people who inject drugs: a systematic review of global, regional, and national coverage

(2010) Bradley M Mathers et al.   LANCET

Barriers to access to antiretroviral treatment in developing countries: a review

(2010) Mariana Posse et al.   TROPICAL MEDICINE & INTERNATIONAL HEALTH

Costs and outcomes of VCT delivery models in the context of scaling up services in Indonesia

(2010) Adiatma Y. M. Siregar et al.   TROPICAL MEDICINE & INTERNATIONAL HEALTH

Human immunodeficiency virus, hepatitis B and hepatitis C in an Indonesian prison: prevalence, risk factors and implications of HIV screening

(2010) Erni J. Nelwan et al.   TROPICAL MEDICINE & INTERNATIONAL HEALTH

Further benefits by early start of HIV treatment in low income countries: Survival estimates of early versus deferred antiretroviral therapy

(2010) Kjell Johansson et al.   AIDS Research and Therapy

Routine versus clinically driven laboratory monitoring of HIV antiretroviral therapy in Africa (DART): a randomised non-inferiority trial

(2009)   LANCET

Mortality of Patients Lost to Follow-Up in Antiretroviral Treatment Programmes in Resource-Limited Settings: Systematic Review and Meta-Analysis

(2009) Martin W. G. Brinkhof et al.   PLoS One

Early and Late Direct Costs in a Southern African Antiretroviral Treatment Programme: A Retrospective Cohort Analysis

(2009) Rory Leisegang et al.   PLOS MEDICINE

Can antiretroviral therapy eliminate HIV transmission?

(2008) Kevin M De Cock et al.   LANCET

Universal voluntary HIV testing with immediate antiretroviral therapy as a strategy for elimination of HIV transmission: a mathematical model

(2008) Reuben M Granich et al.   LANCET